Mednet Logo
HomePulmonology
Pulmonology

Pulmonology

Physician discussions on respiratory conditions, critical care, interstitial lung disease, and pulmonary procedures.

Recent Discussions

Is methacholine challenge on its way out?

2
1 Answers

Mednet Member
Mednet Member
Pulmonology · University of Louisville

I have not needed to order the challenge test for a long time now. I see the need for this test is declining.

Do you perform routine interval lung cancer screening in non-smokers who are 1st degree relatives of patients with non-smoking related lung cancers with known EGFR mutations?

2
3 Answers

Mednet Member
Mednet Member
Pulmonology · Rogel Cancer Center/University of Michigan

I would not. Although there may be a measurable increase in the risk of lung cancer detected in population studies, the absolute risk is probably far below the equivalent of even a low-risk, current or former tobacco user. This is a hard conversation to have with people who believe their risk to be ...

What is your approach to therapy in patients with progressive Scedosporium pulmonary infection who are not candidates for surgical debridement?

2
1 Answers

Mednet Member
Mednet Member
Pulmonology · Emory University Afflilated Hospitals & Clinics

Scedosporium species are increasingly common clinical isolates in patients with bronchiectasis (both CF and NCFBE). There are precious few publications describing these infections in immune-competent hosts, but it seems that these infections tend to be symptomatic (rather than asymptomatic colonizat...

Would you consider using DOACs as a bridge to warfarin instead of heparin or LMWH?

5
4 Answers

Mednet Member
Mednet Member
Cardiology · Hunterdon Cardiovascular Associates

I would feel very comfortable bridging with apixaban, given its relatively short half-life and fairly quick absorption. I think it is very similar to bridging with Lovenox. More importantly, it usually takes at least 24 hours until heparin IV gets to therapeutic levels - it is often too high or too ...

Do you recommend automatically starting CRRT anticoagulation when initiating CRRT if there are no medical contraindications to anticoagulation?

2 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

Great question. My practice is that we don't. However, I wonder if we should. In any case, it is not unreasonable not to give it at the beginning and start it if the patient clots daily or more often. I think bleeding episodes tend to be very dramatic at times and result in clouding our judgement a ...

How would you approach the workup and management of isolated inflammatory subglottic stenosis in a young previously healthy patient that is steroid responsive with a completely negative serologic autoimmune workup?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

This is a relatively unusual situation in that idiopathic subglottic stenosis is typically not managed with systemic immunosuppression. The typical therapies are endoscopic and include dilatation (+/- intralesional corticosteroids), endoscopic resection, and cricotracheal resection. A recent large t...

What is your preferred biologic in children and adolescents with T2 high asthma?

1
1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Indiana University School of Medicine

It depends on patient age, biomarkers (IgE levels, eosinophil counts, FeNO, allergy testing results), comorbidities, what insurance will cover, and how frequently a patient can tolerate injections, adverse effects. Also, clinical outcomes such as wanting to improve FEV1 can play a role in the decisi...

Do you preferentially avoid use of piperacillin-tazobactam for empiric anti-pseudomonal coverage in hospitalized patients due to risk of nephrotoxicity?

1
1 Answers

Mednet Member
Mednet Member
Infectious Disease · Stanford

The bulk of published data indicates that the onset of nephrotoxicity in patients receiving piperacillin-tazobactam plus vancomycin seldom occurs before 3 days of the combination. Thus, I do not object to initiation of this combination empiric therapy, but, as in all cases, therapy must be reevaluat...

How does your approach to subsegmental PE differ from segmental PE both diagnostically and therapeutically?

6
3 Answers

Mednet Member
Mednet Member
Hematology · University of Rochester School of Medicine and Dentistry

My approach to subsegmental PE and segmental PE generally tends to be very similar. I am aware of the CHEST guidelines which indicate patients can safely be observed with subsegmental PE, but like a recent study showed (Rouleau et al., PMID 37531107), uptake of these guidelines is slow and many pati...

Do add a macrolide for immunomodulatory effect in patients with macrolide-resistant M. abscessus?

2 Answers

Mednet Member
Mednet Member
Pulmonology · Hospital of the University of Pennsylvania

I think using azithromycin is something that definitely can be considered, but on an individual basis; if there is significant bronchiectasis with exacerbations, then it makes sense to consider azithromycin; more likely to consider also if there are other microorganisms, especially Pseudomonas drivi...